NO20070366L - Fremgangsmate for fremstilling av 3-(4- piperidinyl)-2,3,4,5-tetrahydro-l,3-benzodiazepin -2(1H)-ON - Google Patents

Fremgangsmate for fremstilling av 3-(4- piperidinyl)-2,3,4,5-tetrahydro-l,3-benzodiazepin -2(1H)-ON

Info

Publication number
NO20070366L
NO20070366L NO20070366A NO20070366A NO20070366L NO 20070366 L NO20070366 L NO 20070366L NO 20070366 A NO20070366 A NO 20070366A NO 20070366 A NO20070366 A NO 20070366A NO 20070366 L NO20070366 L NO 20070366L
Authority
NO
Norway
Prior art keywords
benzodiazepine
piperidinyl
tetrahydro
preparation
migraine
Prior art date
Application number
NO20070366A
Other languages
English (en)
Inventor
Norbert Birk
Ludwig Gutschera
Heidelore Heimroth
Thomas Krueger
Juergen Schnaubelt
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34925890&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20070366(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20070366L publication Critical patent/NO20070366L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Foreliggende oppfinnelse omhandler en fremgangsmåte for fremstilling av forbindelsen 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-on med formel (I), som er å finne som strukturelement i CGRP-antagonister, som spesielt er egnet for oral behandling av migrene.
NO20070366A 2004-07-23 2007-01-19 Fremgangsmate for fremstilling av 3-(4- piperidinyl)-2,3,4,5-tetrahydro-l,3-benzodiazepin -2(1H)-ON NO20070366L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04017424A EP1619187A1 (de) 2004-07-23 2004-07-23 Verfahren zur Herstellung von 3-(4-Piperidinyl)- 2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-on
PCT/EP2005/007778 WO2006010511A1 (de) 2004-07-23 2005-07-16 Verfahren zur herstellung 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1h)-on

Publications (1)

Publication Number Publication Date
NO20070366L true NO20070366L (no) 2007-02-06

Family

ID=34925890

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070366A NO20070366L (no) 2004-07-23 2007-01-19 Fremgangsmate for fremstilling av 3-(4- piperidinyl)-2,3,4,5-tetrahydro-l,3-benzodiazepin -2(1H)-ON

Country Status (19)

Country Link
US (1) US7141667B2 (no)
EP (2) EP1619187A1 (no)
JP (1) JP4516118B2 (no)
KR (1) KR20070046881A (no)
CN (2) CN102040590A (no)
AR (1) AR050352A1 (no)
AU (1) AU2005266579A1 (no)
BR (1) BRPI0513468A (no)
CA (1) CA2572811C (no)
EA (1) EA011260B1 (no)
EC (1) ECSP077190A (no)
IL (1) IL180848A0 (no)
MX (1) MX2007000906A (no)
NO (1) NO20070366L (no)
NZ (1) NZ553294A (no)
TW (1) TW200613283A (no)
UA (1) UA87507C2 (no)
WO (1) WO2006010511A1 (no)
ZA (1) ZA200609919B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101146799A (zh) 2005-03-23 2008-03-19 贝林格尔·英格海姆国际有限公司 Cgrp拮抗剂、其制备方法以及其作为药物的用途
US7473778B2 (en) * 2005-12-24 2009-01-06 Boehringer Ingelheim International Gmbh 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-one
DE102007038251A1 (de) 2007-08-13 2009-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Herstellverfahren
EP2251338A3 (de) 2007-11-22 2011-06-08 Boehringer Ingelheim International GmbH Organische Verbindungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474090A (en) * 1966-12-22 1969-10-21 American Cyanamid Co 3-aminoalkyl-1,3-benzodiazepin-2-ones
FR2518544A1 (fr) * 1981-12-22 1983-06-24 Lipha Benzodiazepines-1,3 thione-2, procede de preparation et medicament les contenant
DE19911039A1 (de) * 1999-03-12 2000-09-14 Boehringer Ingelheim Pharma Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
FR2791021B1 (fr) * 1999-03-16 2001-05-11 France Design Arceau de protection pour vehicule decouvrable a toit repliable

Also Published As

Publication number Publication date
CA2572811A1 (en) 2006-02-02
CN102040590A (zh) 2011-05-04
US7141667B2 (en) 2006-11-28
NZ553294A (en) 2009-07-31
TW200613283A (en) 2006-05-01
AR050352A1 (es) 2006-10-18
CA2572811C (en) 2012-09-11
JP2008507484A (ja) 2008-03-13
WO2006010511A1 (de) 2006-02-02
IL180848A0 (en) 2007-07-04
MX2007000906A (es) 2007-04-13
BRPI0513468A (pt) 2008-05-06
ZA200609919B (en) 2008-07-30
EP1619187A1 (de) 2006-01-25
WO2006010511A8 (de) 2006-05-18
UA87507C2 (en) 2009-07-27
CN1989114A (zh) 2007-06-27
KR20070046881A (ko) 2007-05-03
JP4516118B2 (ja) 2010-08-04
AU2005266579A1 (en) 2006-02-02
US20060019946A1 (en) 2006-01-26
EP1773789A1 (de) 2007-04-18
EA200700041A1 (ru) 2007-08-31
EA011260B1 (ru) 2009-02-27
ECSP077190A (es) 2007-03-29

Similar Documents

Publication Publication Date Title
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
NO20083909L (no) Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere
DE602005008558D1 (de) Kondensierte heterocyclische verbindungen und deren verwendung als antagonisten des metabotropen reznkungen
NO20075406L (no) Pyrimidindionerivater som prokineticin-2-reseprorantagonister
NO20054404L (no) 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon
NO20061137L (no) Cyklopropylderivater som NK3-reseptorantagonister
NO20082719L (no) Aryl-isoksazol-4-yl-oksadiazolderivater
NO20060195L (no) Kinolylamidderivater som CCR-5-antagonister
PE20060878A1 (es) 2-fenil-indoles como antagonistas del receptor de la prostaglandina d2
WO2006041830A3 (en) Cgrp receptor antagonists
NO20080445L (no) Nye azetidinderivater som neurokininreseptorantagonister for behandling av gastrointestinale sykdommer
NO20092689L (no) Quinuclidinolderivater som muskarin reseptorantagonister
PE20040833A1 (es) Derivado de 1-aminociclohexano sustituidos en la posicion 4
NO20081001L (no) Derivater av karboksamid som antagonister for muskarinisk reseptor
NO20053561L (no) Mettede kinoksalinderivater og deres anvendelse som metabotrofe og glutamatreseptorligander
NO20070366L (no) Fremgangsmate for fremstilling av 3-(4- piperidinyl)-2,3,4,5-tetrahydro-l,3-benzodiazepin -2(1H)-ON
MX2009006636A (es) Nuevos intermediarios y procesos utiles en la rpeparacion de {2-[1-(3,5-bis-trifluorometil-bencil)-5-piridin-4-il-1h-[1,2,3]tr iazol-4-il]-piridin-3-il}-(2-clorofenil)-metanona.
US20130143931A1 (en) 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanomethylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as nk1 receptor antagonists
PE20071168A1 (es) Compuestos derivados de 5,6-difenilfuro[2,3-d]pirimidina como activadores no prostanoides del receptor ip
PE20061196A1 (es) Tetrahidropiridoazepin-8-onas y compuestos relacionados para el tratamiento de la esquizofrenia
CA2886117A1 (en) Indoline compounds and their use as aldosterone synthase inhibitors
NO20063562L (no) Fusjonerte heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
TW200732319A (en) 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-one
ATE461172T1 (de) Azetidinderivate als antagonisten des muskarinrezeptors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application